The global high-resolution anoscopy market is projected to witness a steady growth trajectory with a compound annual growth rate (CAGR) of 6% from 2022 to 2032, according to a recent report by Future Market Insights. The market is expected to surge from its current valuation of USD 13.93 billion in 2022 to reach USD 24.95 billion by 2032.
High-resolution anoscope (HRA) is a critical tool used for the early detection of anal dysplasia and other precancerous conditions, particularly among high-risk populations. The growing awareness of the importance of early diagnosis in preventing colorectal cancers, combined with technological advancements in anoscope, is propelling the demand for HRA procedures globally.
Key Market Drivers:
- Increasing Incidence of Colorectal Cancer: Rising cases of colorectal cancer and anal dysplasia are driving the need for high-resolution anoscope to ensure early diagnosis and treatment.
- Advancements in Diagnostic Technologies: Improvements in anoscope technologies are providing healthcare professionals with enhanced visualization capabilities, leading to more accurate diagnoses.
- Focus on Preventative Healthcare: The growing emphasis on preventive healthcare and early cancer detection, especially in high-risk groups such as individuals with a history of human papillomavirus (HPV) infection, is boosting market growth.
As healthcare providers increasingly adopt high-resolution anoscopy for diagnostic purposes, the market is expected to continue its expansion. This trend is further supported by the rising number of clinical studies and research efforts focused on improving detection rates and treatment outcomes for colorectal cancers.
High-Resolution Anoscopy, an avant-garde diagnostic procedure, has emerged as a linchpin in the assessment of various anal conditions. This includes its pivotal role in scrutinizing anal dysplasia—a phenomenon characterized by abnormal cell growth in the anal canal—and anal cancer. The profound significance of this cutting-edge diagnostic technique lies in its ability to facilitate early detection, thereby streamlining treatment modalities and improving patient outcomes.
At the heart of this medical advancement is the anoscope—a small-diameter plastic or metal hollow tube, slightly broader than a finger, with an insert known as the ‘obturator.’ Measuring approximately 5 inches in length, the anoscope is inserted into the anal canal. Upon removal of the obturator, medical practitioners gain a direct visual insight into the rectum. The tube is equipped with a light source, enabling healthcare professionals to examine the lining of the anal canal and lower rectum.
Anoscopy, unlike colonoscopy, is used for looking at the lower rectum and anal canal. A colonoscopy does examine colon on the whole and makes use of different instrument like flexible tube with camera. On the other hand, anoscopy is aa less invasive and shorter procedure as compared to colonoscopy. The good part is that it does not need general anesthesia.
High-resolution anoscopy, in simple terms, is could be referred to as ‘anoscopy with magnification’. Apart from anoscope (that tends to keep anus open), doctor makes use of another device termed as ‘colposcope’. It’s a high-resolution mobile microscope that is connected to monitor. Doctor utilizes this colposcope for closely examining the areas under suspicion in anal canal via anoscope. To better observe suspicious areas, doctor may apply acetic acid to cotton swab or a gauze and also leave inside the anus for some time. This acid does react with some abnormal cells, so as to make them appear white.
Anoscopy does follow an ‘anal Pap test’, which detects abnormal changes, particularly if you are at a higher risk of anal cancer or anal dysplasia. It needs to be noted that anoscopy gets performed when digital rectal exam (using a finger for feeling any abnormalities inside anus) fails to provide appropriate information for making a diagnosis. The doctor may also go ahead with recommending anoscopy if symptoms like pain in/near the anus, rectal bleeding fecal incontinence/constipation, anal itching are seen. Thus, conditions like hemorroids and abscess, anal fistulas (holes) and fissures (tears), rectal lesions, polyps, cancers and tumors, and rectal prolapse could be detected. Anoscopy does not need much of the preparations except having the bowel emptied before the procedure.
The doctor, 24 hours prior to starting with the procedure, may advise avoidance of anal sex, putting anything unnecessary into the anus, and usage of douche and creams. Future Market Insights has entailed these facts with future perspectives in its latest market study entitled ‘Global High-Resolution Anoscopy Industry’. The team of analysts and consultants is there to execute its bottom-up approach with macros as well as micros in place.
“Rising geriatric population is likely to take the high-resolution anoscopy market by storm in the forecast period”, says an analyst from Future Market Insights.
Key Takeaways from High-Resolution Anoscopy Market
- North America holds the largest market share due to the US being subject to advanced healthcare followed by many key players being present over here.
- Europe comes in second on the similar grounds and the scenario is expected to remain the same even in the forecast period.
- With growing awareness regarding high-resolution anoscopy, the Asia-Pacific is expected to grow at a sizable rate in the forecast period.
High-Resolution Anoscopy Market Competitive Analysis
- Apyx Medical is known for its Renuvion and J-Plasma helium plasma technologies.
- Gynius has its ‘Gynocular’ – a leading portable optical colposcope to conduct digital biopsy regarding cervical cancer.
Key Companies Profiled:
- Carl Zeiss AG
- SEILER GAREPA PVT. LTD
- Optomic
- Lutech
- Medimarcorp.
- Ecleris
- Gynius Plus AB
- Bovie Medical Corporation
- GoldCare
Key Segments Profiled in the High-Resolution Anoscopy Market Survey
By Product Type:
- Colposcopes
- Portable Colposcope
- Hand-Held Colposcope
- Anoscopes
- Disposable Anoscope
- Reusable Anoscope
By End Use:
- Hospitals
- Diagnostic Laboratories
- Specialty Clinics
Author
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
